Idexx Laboratories Inc
$511.65
$5.17 (+1.02%)
$505.21Day Range$516.43
Key Statistics
Market Cap
$40.31B
Shares Outstanding
78.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 21, 1991
Round Lot
40
Locale
US
Trading Data
Day Open
$506.48
Day High
$516.43
Day Low
$505.21
Volume
1.12M
VWAP
$511.48
Prev Close
$506.48
Transactions
--
Acc. Volume
--
About Idexx Laboratories Inc
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESSIC 283511,000 employeesONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041(207) 556-0300IPO Jun 21, 1991US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000874716
- Composite FIGI
- BBG000BLRT07
- Share Class FIGI
- BBG001S5S4Y9
- Ticker Root
- IDXX
- SIC Code
- 2835
About Idexx Laboratories Inc (IDXX) Stock
Idexx Laboratories Inc (IDXX) closed the 2026-09-18 session at $511.65, up 1.02% versus the previous close (+5.17). The stock opened at $506.48 and traded between $505.21 and $516.43 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $511.48.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Idexx Laboratories Inc has a market capitalization of $40.31 billion. The company operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry classification. IDXX is listed on the XNAS exchange. The company employs approximately 11,000 people. Idexx Laboratories Inc is headquartered in WESTBROOK, ME. The recorded listing date is 1991-06-21.
On this page you can find market IDXX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.